Aurora Cannabis Inc.

ACB

$3.38

Name : Aurora Cannabis Inc.

Sector : Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Mark. Cap: $199,847,936.00

EPSttm : -1.07

Aurora Cannabis Inc.

$3.38

0.88%

$0.03

ACB — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

12.92

Margin Of Safety %

Put/Call OI Ratio

0.58

EPS Next Q Diff

-0.17

EPS Last/This Y

EPS This/Next Y

1.18

Price

3.38

Target Price

5.3

Analyst Recom

Performance Q

-4.52

Upside

-1,270.1%

Beta

0.55

Ticker: ACB

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	ACB	3.43	0.51	1.81	46600
2026-05-12	ACB	3.37	0.52	0.24	46369
2026-05-13	ACB	3.36	0.51	0.26	46512
2026-05-14	ACB	3.36	0.51	0.21	46659
2026-05-15	ACB	3.32	0.51	0.12	46676
2026-05-18	ACB	3.29	0.65	0.16	38661
2026-05-19	ACB	3.31	0.65	1.24	38881
2026-05-20	ACB	3.47	0.64	0.40	38964
2026-05-21	ACB	3.56	0.64	0.27	39764
2026-05-22	ACB	3.47	0.62	2.29	40076
2026-05-26	ACB	3.47	0.60	0.28	39796
2026-05-27	ACB	3.47	0.60	0.04	40087
2026-05-28	ACB	3.67	0.59	0.10	40244
2026-05-29	ACB	3.62	0.59	0.18	40513
2026-06-02	ACB	3.51	0.57	0.81	41541
2026-06-03	ACB	3.43	0.57	1.22	41743
2026-06-04	ACB	3.53	0.58	0.50	42029
2026-06-05	ACB	3.38	0.58	0.49	42099
2026-06-08	ACB	3.43	0.58	1.11	42261
2026-06-09	ACB	3.38	0.58	0.15	42463
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	ACB	3.43	-	-	-1.23
2026-05-12	ACB	3.36	-	-	-1.23
2026-05-13	ACB	3.35	-	-	-1.23
2026-05-14	ACB	3.36	-	-	-1.23
2026-05-15	ACB	3.32	-	-	-1.23
2026-05-18	ACB	3.29	-	-	-1.23
2026-05-19	ACB	3.30	-	-	-1.23
2026-05-20	ACB	3.47	-	-	-1.23
2026-05-21	ACB	3.57	-	-	-1.23
2026-05-22	ACB	3.48	-	-	-1.23
2026-05-26	ACB	3.47	-	-	-1.23
2026-05-27	ACB	3.47	-	-	-1.23
2026-05-28	ACB	3.67	-	-	-1.23
2026-05-29	ACB	3.62	-	-	-1.23
2026-06-01	ACB	3.64	-	-	-1.23
2026-06-02	ACB	3.54	-	-	-1.23
2026-06-03	ACB	3.43	-	-	-1.23
2026-06-04	ACB	3.52	-	-	-1.23
2026-06-05	ACB	3.39	-	-	-1.23
2026-06-08	ACB	3.42	-	-	-1.23
2026-06-09	ACB	3.38	-	-	-1.23
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	ACB	0.00	-2.78	11.86
2026-05-12	ACB	0.00	-2.78	13.62
2026-05-13	ACB	0.00	-2.78	13.62
2026-05-14	ACB	0.00	-2.78	13.62
2026-05-15	ACB	0.00	-2.78	13.62
2026-05-18	ACB	0.00	-3.13	13.62
2026-05-19	ACB	0.00	-3.13	13.62
2026-05-20	ACB	0.00	-3.13	13.62
2026-05-21	ACB	0.00	-3.13	13.62
2026-05-22	ACB	0.00	-3.13	13.62
2026-05-26	ACB	0.00	-2.36	13.62
2026-05-27	ACB	0.00	-2.36	13.62
2026-05-28	ACB	0.00	-2.36	12.92
2026-05-29	ACB	0.00	-2.36	12.92
2026-06-02	ACB	0.00	-2.37	12.92
2026-06-03	ACB	0.00	-2.37	12.92
2026-06-04	ACB	0.00	-2.37	12.92
2026-06-05	ACB	0.00	-2.37	12.92
2026-06-08	ACB	0.00	-2.37	12.92
2026-06-09	ACB	0.00	-2.37	12.92
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.09

Avg. EPS Est. Current Quarter

-0.14

Avg. EPS Est. Next Quarter

-0.08

Insider Transactions

Institutional Transactions

-2.37

Beta

0.55

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

96.8

Max Drawdown 5-Year %

-97.2

Target Price

5.3

P/E

Forward P/E

24.02

PEG

0.89

P/S

0.72

P/B

0.49

P/Free Cash Flow

EPS

-1.13

Average EPS Est. Cur. Y

-1.23

EPS Next Y. (Est.)

-0.05

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-23.85

Relative Volume

0.72

Return on Equity vs Sector %

-43.3

Return on Equity vs Industry %

-23.8

EPS 1 7Days Diff

-0.3

EPS 1 30Days Diff

-0.52

EBIT Estimation

◆ ACB Healthcare

$3.38

📉

Swing / Pullback

Buy the dip on strong trends

WATCH

Trend

7/20

Pullback

19/25

Volume

9/15

Valuation

15/20

TP/AR

1/10

Options

5/10

RSI

Range 1M

37.2%

Sup Dist

0.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

2/25

Growth

11/30

Estimates

1/20

Inst/Vol

0/15

Options

8/10

EPS Yr

-893.6%

EPS NY

116.2%

52W%

9.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +56.8% upside

Quality

2/30

Valuation

14/30

Growth

7/25

Stability

6/10

LT Trend

3/5

Upside

+56.8%

Quality

Aurora Cannabis Inc.

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees:

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables and floral plants. It also provides dried and fresh cannabis, cannabis oils, trims, concentrates, ingestibles, capsules, vaporizers, edible cannabis, cannabis extracts, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes San Rafael '71, Greybeard, Drift, Daily Special, Being, CanniMed, MedReleaf, Aurora, and WMMC, as well as international brands include Pedanios, Bidiol, IndiMed, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.

ACB

Latest News

—

Caricamento notizie per ACB…

stock quote shares ACB – Aurora Cannabis Inc. Stock Price stock today

news today ACB – Aurora Cannabis Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ACB – Aurora Cannabis Inc. yahoo finance google finance

stock history ACB – Aurora Cannabis Inc. invest stock market

stock prices ACB premarket after hours

ticker ACB fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ACB

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y